AbbVie
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AbbVie and other ETFs, options, and stocks.About ABBV
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.
ABBV Key Statistics
ABBV News
On Thursday, AbbVie Inc. ABBV reported second-quarter adjusted EPS of $2.65, down 8.9% year over year, beating the consensus of $2.57. Net revenues reached $14...
AbbVie (NYSE:ABBV) has discontinued a Phase 2 program for its Alzheimer’s therapy, ABBV-916, citing the candidate’s lack of differentiation from the currently a...
Participants Liz Shea; Investor Relations; AbbVie Inc Robert Michael; President, Chief Executive Officer, Director; AbbVie Inc Jeffrey Stewart; Executive Vic...
Analyst ratings
67%
of 30 ratingsMore ABBV News
AbbVie shares rose as much as 5% early Thursday after the drugmaker said newer drugs helped soften a drop in quarterly sales from its blockbuster immunology tre...
AbbVie Is About To Have A New Golden Goose As Humira Sales Continue Slowing...
AbbVie (ABBV) reported strong results for the second quarter. The company announced adjusted diluted earnings of $2.65 per share, which is an 8.9% decrease year...
In this article: AbbVie's Q2 Earnings Beat Estimates, Raises Annual Profit On Strong Sales From Newer Immunology And Cancer Drugs On Thursday, AbbVie Inc. (NY...
Cerevel Therapeutics (NASDAQ:CERE) rose almost 1% in premarket trading after AbbVie (NYSE:ABBV) said it expects its planned acquisition to close soon. AbbVie (...
(Reuters) — AbbVie (ABBV) raised its annual profit forecast on Thursday as strong sales of its key immunology drugs, including Humira, helped it beat Wall Stree...
Today, several major companies are expected to report earnings: AstraZeneca (AZN), Honeywell International (HON), Royal Caribbean (RCL), Southwest Airlines (LUV...